Tissue-Resident Memory T Cell

Tissue-resident memory T cells (T_RM cells) are a lineage of long-lived, non-recirculating memory CD8⁺ and CD4⁺ T lymphocytes that take up permanent residence inside non-lymphoid peripheral barrier and parenchymal tissues—including the skin epidermis, intestinal lamina propria and intraepithelial compartment, respiratory mucosa, female reproductive tract, liver sinusoids, and brain parenchyma—without returning to the bloodstream or efferent lymphatics. Identified in 2001–2009 by David Masopust, Rafi Ahmed, Leo Lefrançois, Francis R. Carbone, Thomas S. Gebhardt, and Thomas S. Kupper using parabiotic mouse surgery and skin-grafting models, T_RM cells revise the classical two-subset paradigm of circulating immunological memory (central memory T_CM and effector memory T_EM formulated by Federica Sallusto and Antonio Lanzavecchia in 1999). By remaining physically anchored at exact portals of pathogen entry via CD69-mediated antagonism of S1PR1 and CD103 (α_Eβ₇ integrin) binding to epithelial E-cadherin, T_RM cells eliminate the 48-to-96-hour anatomical delay required for circulating memory T cells to be recruited from blood or lymph nodes, executing immediate in situ cytotoxicity and triggering an organ-wide "sense-and-alarm" innate antiviral state within hours of secondary pathogen encounter.

Parabiotic Surgery and Skin-Transplant Proofs of Non-Recirculation

In 1999, Sallusto and Lanzavecchia partitioned human peripheral blood memory T cells into two recirculating subsets based on expression of the lymph-node homing receptors CCR7 and CD62L (L-selectin):

• Central Memory T Cells (T_CM, CCR7⁺CD62L⁺): Continuously enter secondary lymphoid organs across high endothelial venules, patrol T-cell zones, and return to the venous circulation via efferent lymphatics and the thoracic duct.
• Effector Memory T Cells (T_EM, CCR7⁻CD62L⁻): Circulate through blood and non-lymphoid vascular beds, entering inflamed tissues and draining back into lymphatics.

However, in 2001, David Masopust, Leo Lefrançois, and colleagues observed large, durable populations of virus-specific CD8⁺ memory T cells persisting inside the intestinal lamina propria, lung, and kidney months after vesicular stomatitis virus (VSV) or lymphocytic choriomeningitis virus (LCMV) clearance. In 2006–2009, Klonowski et al. and Thomas Gebhardt, Francis Carbone, and colleagues joined the circulatory systems of congenic mice via parabiotic surgery and transplanted herpes simplex virus (HSV)-immune dorsal root ganglia and skin grafts onto naive recipients. Whereas circulating T_CM and T_EM cells equilibrated 50:50 between the two parabiotic partners' blood and spleens within 14 days, >95% of epidermal and mucosal CD103⁺CD69⁺ memory T cells never entered the shared bloodstream, remaining permanently stationed inside their host barrier epithelium and clearing secondary viral challenges days before circulating memory T cells could infiltrate the site. Quantitative whole-body histological mapping by Masopust and Donna L. Farber subsequently revealed that in adult humans and free-living mammals, T_RM cells outnumber all circulating T_CM and T_EM cells combined, constituting the largest T-cell compartment in the human body.

To convert an infiltrating KLRG1^lowCD127^high memory precursor effector cell (MPEC) into a permanent tissue resident, local stromal and epithelial signals execute a coordinated three-part molecular lock:

1. Downregulation of KLF2 and CD69-Mediated Degradation of S1PR1

For any lymphocyte to exit a peripheral tissue or lymph node, it must sense the steep chemotactic gradient of sphingosine-1-phosphate (S1P) (which is low inside tissue interstitial fluid, <10 nM, but high in afferent/efferent lymph and blood plasma, 100–1,000 nM) using S1P receptor 1 (S1PR1), or sense lymphatic endothelial CCL21 using CCR7.

• When effector T cells enter an infected barrier tissue, local cytokines (TGF-β, TNF-α, IL-33, and Type I interferons) rapidly silence the transcription factor Kruppel-like factor 2 (KLF2)—the master transcriptional activator of both S1pr1 and Sell (CD62L).
• Simultaneously, T_RM precursors constitutively express the C-type lectin CD69 (not as a transient activation marker, but as a permanent residency protein). The transmembrane domain of CD69 physically complexes in cis with any remaining S1PR1 on the T-cell membrane, forcing S1PR1 into an agonist-bound conformation that triggers its rapid internalization and lysosomal degradation. Deprived of surface S1PR1 and CCR7, the T_RM cell becomes completely blind to lymphatic egress signals.

2. TGF-β-Driven Induction of Epithelial Anchors: CD103 (α_Eβ₇) and CD49a (α₁β₁)

Within epithelial barriers (skin epidermis, intestinal intraepithelial layer, lung bronchial epithelium, and salivary/mammary ducts), keratinocytes and dendritic cells activate latent transforming growth factor-beta (TGF-β) via α_vβ₆ and α_vβ₈ integrins. TGF-β signaling through SMAD2/3 and the transcription factor Runx3 downregulates the T-box factor Eomesodermin (Eomes) and strongly induces the ITGAE gene encoding CD103 (integrin α_E), which heterodimerizes with integrin β₇ to form α_Eβ₇.

• CD103 (α_Eβ₇) binds directly to E-cadherin, the adherens-junction protein expressed on all mucosal and epidermal epithelial cells, tethering Intraepithelial T_RM cells directly to the epithelial basolateral lattice as dendritic-shaped sentries.
• Concurrently, T_RM cells upregulate CD49a (integrin α₁β₁ / VLA-1), which binds Type IV collagen in the subepithelial basement membrane, and CXCR6, which binds transmembrane CXCL16 on airway and hepatic sinusoidal cells. (In non-epithelial organs lacking E-cadherin, such as the liver sinusoids or secondary lymphoid organs, CD69⁺CD103⁻ T_RM cells rely instead on LFA-1–ICAM-1 and CXCR6–CXCL16 for intravascular and stromal retention).

3. The Hobit–Blimp-1–Runx3 Transcriptional Triad and FABP4/5 Lipid Metabolism

As demonstrated by Klaas van Gisbergen, Laura K. Mackay, and Ananda W. Goldrath (2016–2017), the universal tissue-residency gene program across CD8⁺ T_RM, natural killer T (NKT) cells, and innate lymphoid cells (ILC1) is controlled by two homologous zinc-finger transcriptional repressors—Hobit (ZNF683, Homolog of Blimp-1 in T cells) and Blimp-1 (PRDM1)—acting alongside Runx3 and Bhlhe40:

• Hobit and Blimp-1 bind directly to target sequences within the Klf2, S1pr1, Ccr7, and Tcf7 loci, epigenetically silencing all tissue-egress genes while maintaining constitutive transcription of Gzmb (Granzyme B) so T_RM cells remain armed for immediate cytolysis.
• Metabolic Adaptation to Lipid-Rich Barrier Tissues (FABP4 and FABP5): As discovered by Thomas S. Kupper and colleagues (2017), epidermal and mucosal T_RM cells survive for years in nutrient-restricted interstitial microenvironments by upregulating peroxisome proliferator-activated receptor-gamma (PPAR-γ) and the tissue-specific fatty acid-binding proteins FABP4 and FABP5 (taking on the specific FABP isoform signature of their host organ), enabling them to import extracellular free fatty acids directly from the surrounding tissue to fuel carnitine palmitoyltransferase 1A (CPT1A)-dependent mitochondrial β-oxidation.

Organ-Wide Antiviral Conditioning within Hours of Reinfection

When a pathogen breaches an epithelial surface, local T_RM cells do not merely lyse the first infected epithelial cell via perforin and granzyme B; as shown by Schenkel, Fraser, and Masopust (2013–2014), cognate antigen recognition by a small number of CD8⁺ T_RM cells triggers an explosive "sense-and-alarm" paracrine cascade:

1. IFN-γ-Induced Tissue-Wide Antiviral State: Within 2 to 6 hours of TCR engagement (or innate cytokine bystander activation by IL-12 + IL-18), T_RM cells secrete high local concentrations of interferon-gamma (IFN-γ), which induces hundreds of interferon-stimulated genes (ISGs: IFITM3, MX1, OAS1, ISG15) across thousands of surrounding uninfected epithelial cells, rendering the entire mucosal patch refractory to even unrelated heterotypic viruses.
2. TNF-α and IL-2 Licensing of Vascular Endothelium and NK/DC Cells: T_RM-derived TNF-α upregulates VCAM-1 and CXCL9/CXCL10 on local post-capillary venules to rapidly recruit circulating B cells and memory T cells from the bloodstream, while T_RM-derived IL-2 and XCL1 activate local natural killer cells and cDC1 cross-presentation.

Mucosal "Prime-and-Pull" Vaccination vs. Autoimmune Skin Pathology

Because conventional intramuscular mRNA or subunit vaccines induce strong systemic IgG and circulating T_CM/T_EM responses but generate poor mucosal T_RM populations in the nasal airway, lung, or genital tract, Akiko Iwasaki and colleagues (2012) pioneered the "Prime-and-Pull" (and intranasal mucosal booster) immunization strategy: parenteral priming expands systemic effector CD8⁺ T cells in the blood, followed by topical mucosal application of chemokines (CXCL9/CXCL10) or mucosal antigen delivery to pull those circulating effectors into the respiratory or reproductive epithelium to differentiate into protective CD103⁺CD69⁺ T_RM sentries.

Conversely, when aberrant autoreactive or allergen-specific T_RM clones permanently colonize barrier tissues, their longevity and resistance to systemic lymphocyte-depleting therapies explain why autoimmune skin lesions recur in the exact same anatomical patches after treatment withdrawal—most notoriously in psoriasis (driven by epidermal IL-17A-producing CD8⁺CD103⁺CD49a⁻ T_RM17 cells), vitiligo (driven by melanocyte-killing IFN-γ-producing CD8⁺CD103⁺CD49a⁺ T_RM1 cells that recruit circulating T cells via the IFN-γ–JAK1/2–CXCL9/10 axis), and fixed drug eruptions.

1. Gebhardt, T., Wakim, L. M., Eidsmo, L., Reading, P. C., Heath, W. R., & Carbone, F. R. (2009). "Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus." Nature Immunology, 10(5), 524–530. https://doi.org/10.1038/ni.1718
2. Schenkel, J. M., Fraser, K. A., Vezys, V., & Masopust, D. (2013). "Sensing and alarm function of resident memory CD8⁺ T cells." Nature Immunology, 14(5), 509–513. https://doi.org/10.1038/ni.2568
3. Mackay, L. K., Minnich, M., Kragten, N. A. M., Liao, Y., Nota, B., Seillet, C., Zaid, A., Man, K., Preston, S., Freestone, D., Braun, A., Wynne-Jones, E., Behr, F. M., Stark, R., Pellicci, D. G., Godfrey, D. I., Belz, G. T., Pellegrini, M., Gebhardt, T., Busslinger, M., Shi, W., Carbone, F. R., van Lier, R. A. W., Kallies, A., & van Gisbergen, K. P. J. M. (2016). "Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes." Science, 352(6284), 459–463. https://doi.org/10.1126/science.aad2035
4. Pan, Y., Tian, T., Park, C. O., Lofftus, S. Y., Mei, S., Liu, X., Luo, C., O'Malley, J. T., Gehad, A., Teague, J. E., Divito, S. J., Fuhlbrigge, R., Puigserver, P., Krueger, J. G., Hotamisligil, G. S., Clark, R. A., & Kupper, T. S. (2017). "Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism." Nature, 543(7644), 252–256. https://doi.org/10.1038/nature21379